CRAC inhibitors (Johns Hopkins University)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameCRAC inhibitors (Johns Hopkins University)
Drug Alias Namecalcium release activated channel inhibitors (Johns Hopkins University)phenazine derivatives (Johns Hopkins University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium release-activated calcium channel protein 1 blockers
TargetsCalcium release-activated calcium channel protein 1
Therapy Area/IndicationsRejection of organ transplantationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A